Campion Andrew 4

What Happened Andrew Campion, a director of Williams‑Sonoma, reported a grant on May 4, 2026 of 151 deferred stock units (DSUs). The reported transaction is an award/derivative (code A) with an acquisition price of $0.00 — these are not immediate common shares but contingent rights to receive shares in the future. The DSUs were granted in lieu of the cash portion of his annual retainer under the company’s director compensation policy.

Key Details

• Transaction date: 2026-05-04; Form 4 filed: 2026-05-06 (filed timely).
• Instrument: 151 deferred stock units (derivative award); reported acquisition price $0.00.
• Footnote summary:
  • Each DSU represents a contingent right to one share of WSM common stock (F1).
  • DSUs were elected under the Issuer’s 2001 Long‑Term Incentive Plan in lieu of cash retainers (F2).
  • DSUs are fully vested and scheduled for delivery at the end of the deferral period in June 2029, subject to earlier delivery upon certain events (F3).
• Shares owned after the transaction: not specified in the filing.
• No sale or purchase occurred — this is a grant/deferral, not an open‑market trade.

Context Deferred stock units are a common director compensation mechanism that convert into company shares (or cash equivalent) at a later date; they do not represent immediate insider purchases or sales. Because these units were elected instead of cash retainer and are fully vested but subject to a deferral schedule, this filing signals compensation structuring rather than a market‑timed insider trade.